These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21330914)

  • 1. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
    Nielsen VG; George SJ
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
    Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
    Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2.
    Machovec KA; Ushakumari DS; Welsby IJ; Nielsen VG
    Thromb Res; 2012 Jun; 129(6):793-6. PubMed ID: 21872302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
    Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
    Nielsen VG; Ellis TC
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
    Nielsen VG; Garza JI
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide releasing molecule-2 improves coagulation in patient plasma in vitro following cardiopulmonary bypass.
    Malayaman SN; Entwistle JW; Boateng P; Wechsler AS; Persaud JM; Cohen JB; Kirklin JK; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):362-8. PubMed ID: 21346555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
    Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.